File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Glioblastoma outcomes: a three year single centre retrospective review
| Title | Glioblastoma outcomes: a three year single centre retrospective review |
|---|---|
| Authors | |
| Issue Date | 22-Nov-2024 |
| Abstract | Objective: To assess the outcome of glioblastoma patients who underwent treatment at Queen Mary Hospital. Method: Retrospective study of the glioblastoma population who underwent operation from 2020 to 2022, with demographic, molecular profiles, treatment, and survival data collected, further statistical analysis via multivariate analysis. Result: 48 patients were assessed, median overall survival was 10 months, longer survival was associated with debulking surgery rather than biopsy, adjuvant treatment, MGMT promoter methylation, and younger age. Conclusion: Younger age, adjuvant treatment, molecular profile, and debulking was associated with longer survival in glioblastoma patients. |
| Persistent Identifier | http://hdl.handle.net/10722/351823 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Woo, Alexander | - |
| dc.contributor.author | Lau, Sarah Sau-Ning | - |
| dc.contributor.author | Li, Lai-Fung | - |
| dc.contributor.author | Taw, Benedict Beng-Teck | - |
| dc.contributor.author | Ho, Wilson Wai-Shing | - |
| dc.contributor.author | Leung, Gilberto Ka-Kit | - |
| dc.contributor.author | Lui, Wai-Man | - |
| dc.contributor.author | Cheng, Kevin King-Fai | - |
| dc.date.accessioned | 2024-12-01T00:35:13Z | - |
| dc.date.available | 2024-12-01T00:35:13Z | - |
| dc.date.issued | 2024-11-22 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/351823 | - |
| dc.description.abstract | <p><strong><em>Objective</em></strong><strong>:</strong></p><p>To assess the outcome of glioblastoma patients who underwent treatment at Queen Mary Hospital.</p><p><strong><em>Method:</em></strong><br></p><p>Retrospective study of the glioblastoma population who underwent operation from 2020 to 2022, with demographic, molecular profiles, treatment, and survival data collected, further statistical analysis via multivariate analysis.<br></p><p><strong><em>Result:</em></strong><br></p><p>48 patients were assessed, median overall survival was 10 months, longer survival was associated with debulking surgery rather than biopsy, adjuvant treatment, MGMT promoter methylation, and younger age.<br></p><p><strong><em>Conclusion:</em></strong><br></p><p>Younger age, adjuvant treatment, molecular profile, and debulking was associated with longer survival in glioblastoma patients.<br></p> | - |
| dc.language | eng | - |
| dc.relation.ispartof | 31st Annual Scientific Meeting, The Hong Kong Neurosurgical Society, Hong Kong, 22-23 November 2024 (22/11/2024-23/11/2024, Hong Kong) | - |
| dc.title | Glioblastoma outcomes: a three year single centre retrospective review | - |
| dc.type | Conference_Paper | - |